[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU1039292A - Use of nadh and nadph as energy substitutes - Google Patents

Use of nadh and nadph as energy substitutes

Info

Publication number
AU1039292A
AU1039292A AU10392/92A AU1039292A AU1039292A AU 1039292 A AU1039292 A AU 1039292A AU 10392/92 A AU10392/92 A AU 10392/92A AU 1039292 A AU1039292 A AU 1039292A AU 1039292 A AU1039292 A AU 1039292A
Authority
AU
Australia
Prior art keywords
nadh
nadph
reduced form
adenine dinucleotide
nicotinamide adenine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU10392/92A
Other versions
AU663479B2 (en
Inventor
Jorg Birkmayer
Walther Birkmayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1039292A publication Critical patent/AU1039292A/en
Application granted granted Critical
Publication of AU663479B2 publication Critical patent/AU663479B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/153Nucleic acids; Hydrolysis products or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13Nucleic acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Animal Husbandry (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Dental Preparations (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

Use is described of nicotinamide adenine dinucleotide in its reduced form (NADH) and/or nicotinamide adenine dinucleotide phosphate in its reduced form (NADPH) and/or a physiologically tolerated salt of the same for energy substitution in humans or animals, as is a foodstuff or confectionary product for human consumption or a feedstuff for animal consumption having a content of the substances mentioned.
AU10392/92A 1991-01-24 1992-01-23 Use of NADH and NADPH as energy substitutes Ceased AU663479B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4102240A DE4102240C1 (en) 1991-01-24 1991-01-24
DE4102240 1991-01-24

Publications (2)

Publication Number Publication Date
AU1039292A true AU1039292A (en) 1992-07-30
AU663479B2 AU663479B2 (en) 1995-10-12

Family

ID=6423720

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10392/92A Ceased AU663479B2 (en) 1991-01-24 1992-01-23 Use of NADH and NADPH as energy substitutes

Country Status (14)

Country Link
EP (1) EP0496479B1 (en)
JP (1) JP2533709B2 (en)
AT (1) ATE112664T1 (en)
AU (1) AU663479B2 (en)
BR (1) BR9200207A (en)
CA (1) CA2059510C (en)
DE (2) DE4102240C1 (en)
DK (1) DK0496479T3 (en)
ES (1) ES2061313T3 (en)
FI (1) FI920323A (en)
HU (1) HU9200213D0 (en)
IE (1) IE69861B1 (en)
NO (1) NO304672B1 (en)
ZA (1) ZA92275B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2167104A1 (en) * 1995-01-17 1996-07-18 Joerg G.D. Birkmayer Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US5668114A (en) * 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension
IT1318565B1 (en) * 2000-06-09 2003-08-27 World Pharma Tech Ltd NADH OCTOCOSANOL EVITAMIN E PROENERGETIC FOOD SUPPLEMENT
US20040126751A1 (en) * 2002-12-27 2004-07-01 Birkmayer Jorg G.D. Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose
DE102008010245B4 (en) * 2008-02-20 2011-02-10 Emag Holding Gmbh Method for grinding wavy workpieces
DE102014103443A1 (en) * 2014-03-13 2015-09-17 Jürgen Ruhlmann Composition for use in the treatment of fatigue, lack of concentration, withdrawal symptoms, headaches and colds, in particular loss of power, hangover and fatigue
WO2020021734A1 (en) * 2018-07-26 2020-01-30 オリジンバイオテクノロジー株式会社 Functional chicken eggs and method for producing same
DE202022000567U1 (en) 2022-03-06 2022-03-16 Penta Phi Eg Liposomal formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594475A (en) * 1968-04-24 1971-07-20 Kyowa Hakko Kogyo Kk Method of treating and preventing the side effects of antibiotics
DE3380342D1 (en) * 1982-10-26 1989-09-14 Cta Finanz Ag Device and process for optimising the tissue mass of organs within the genetic fluctuation range in humans and animals
IT1162938B (en) * 1983-08-26 1987-04-01 Dino Spisni COMPOSITION FOR THE TREATMENT OF MALIGNANT CANCERS, IN PARTICULAR ON ANIMALS
JPS60126220A (en) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc Nucleic acid component composition
ES2007350A6 (en) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Food products enriched with nucleosides and/or nucleotides and preparation thereof.
JP2736103B2 (en) * 1988-03-01 1998-04-02 ヴァルター・ビルクマイヤー Pharmaceutical for treating Parkinson's syndrome and method for producing the same
AT397201B (en) * 1988-06-03 1994-02-25 Birkmayer Joerg Ddr USE OF THE ENZYME COFACTOR NADPH IN THE PRODUCTION OF A MEDICINAL PRODUCT

Also Published As

Publication number Publication date
EP0496479B1 (en) 1994-10-12
DE4102240C1 (en) 1992-04-09
BR9200207A (en) 1992-10-06
DE59200603D1 (en) 1994-11-17
CA2059510A1 (en) 1992-07-25
CA2059510C (en) 1997-06-10
EP0496479A1 (en) 1992-07-29
ES2061313T3 (en) 1994-12-01
DK0496479T3 (en) 1995-04-18
JP2533709B2 (en) 1996-09-11
AU663479B2 (en) 1995-10-12
FI920323A0 (en) 1992-01-24
ZA92275B (en) 1992-12-30
NO920315D0 (en) 1992-01-23
ATE112664T1 (en) 1994-10-15
NO304672B1 (en) 1999-02-01
NO920315L (en) 1992-07-27
IE69861B1 (en) 1996-10-16
FI920323A (en) 1992-07-25
HU9200213D0 (en) 1992-04-28
IE920198A1 (en) 1992-07-29
JPH05262652A (en) 1993-10-12

Similar Documents

Publication Publication Date Title
AU9062291A (en) Formulation for treating silage
AU653992B2 (en) Novel benzo-fused lactams that promote the release of growth hormone
AU590694B2 (en) Hydratable powders
AU655462B2 (en) Use of hydrocolloids for formulating and processing of low fat water activity confectionery products and process
CA2054358A1 (en) High acid nutritional formulations
CA2102210A1 (en) Combined Calcium and Vitamin D Supplements
AU1039292A (en) Use of nadh and nadph as energy substitutes
DE3867477D1 (en) PREPARATION FOR EXTENDING THE STABILITY OF FOODS, MEDICINAL PRODUCTS AND COSMETIC PRODUCTS.
AU5744286A (en) Potassium, sodium or calcium formate additive for inhibiting respiration of and promoting desiccation of crops
MY106830A (en) Preparation of a cooked product having an improved preservation based on animal proteins.
AU4120589A (en) Supported lactic acid
EP0904701A3 (en) Inactivated micro-organisms containing minerals, process for their preparation, and their use in the food sector
CA2124925A1 (en) Preparation of dietary fatty acid salt products
AU9010991A (en) Antidepressant
ATE217486T1 (en) PRODUCTION OF A VEGETABLE MILK POWDER
GB2016900A (en) Concentrated food product
CA2081348A1 (en) Veterinary formulation of amoxycillin and clavulanic acid, and derivatives thereof
HUT61895A (en) Process for producing pharmaceutical composition against cancer and aids
Annison Feed enzymes: the science of their use in wheat-based diets
AU7392187A (en) Preparation for prophylaxis and treatment of gastro- intestinal disturbances in farm animals
HUT38807A (en) Flavoured synthetic crisp bone of high hardness

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired